BindingDB logo
myBDB logout

BDBM50257199 (S)-2-((S)-2-((S)-2-((S)-1-((S)-6-amino-2-(5-guanidinopentanamido)hexanoyl)pyrrolidine-2-carboxamido)-3-(1H-indol-3-yl)propanamido)-3,3-dimethylbutanamido)-4-methylpentanoic acid::CHEMBL500173

SMILES: CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)CCCCN=C(N)N)C(C)(C)C)C(O)=O

InChI Key: InChIKey=JUKCEHHNUBUMOG-VDYFTJCESA-N

Data: 1 KI  1 IC50  1 EC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50257199   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Dopamine receptor D2L/neurotensin receptor NTS1


(Homo sapiens (Human))
BDBM50257199
PNG
((S)-2-((S)-2-((S)-2-((S)-1-((S)-6-amino-2-(5-guani...)
Show SMILES CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)CCCCN=C(N)N)C(C)(C)C)C(O)=O |r,wU:8.8,wD:26.27,12.24,4.4,33.41,(40.62,-38.86,;40.62,-37.31,;41.99,-36.61,;39.33,-36.48,;39.39,-34.94,;38.1,-34.11,;36.73,-34.82,;36.67,-36.36,;35.44,-33.99,;34.07,-34.69,;32.78,-33.86,;32.85,-32.32,;31.4,-34.57,;31.33,-36.11,;32.63,-36.94,;34.06,-36.38,;35.04,-37.57,;34.2,-38.86,;34.61,-40.35,;33.53,-41.44,;32.04,-41.04,;31.64,-39.56,;32.72,-38.48,;30.1,-33.74,;28.74,-34.46,;27.45,-33.63,;28.67,-36.01,;29.89,-36.97,;29.35,-38.39,;27.8,-38.39,;27.38,-36.87,;26.06,-36.09,;26.07,-34.55,;24.71,-36.84,;24.7,-38.39,;23.36,-39.16,;23.35,-40.7,;22.02,-41.46,;22,-43,;23.38,-36.07,;22.04,-36.84,;22.03,-38.37,;20.71,-36.06,;20.72,-34.52,;19.39,-33.73,;19.4,-32.19,;18.07,-31.41,;18.09,-29.87,;16.76,-29.1,;19.42,-29.11,;35.52,-32.45,;35.51,-30.9,;37.06,-32.48,;33.98,-32.42,;40.76,-34.24,;42.05,-35.07,;40.84,-32.7,)|
Show InChI InChI=1S/C40H64N10O7/c1-24(2)21-30(38(56)57)48-36(54)33(40(3,4)5)49-34(52)29(22-25-23-45-27-14-7-6-13-26(25)27)47-35(53)31-16-12-20-50(31)37(55)28(15-8-10-18-41)46-32(51)17-9-11-19-44-39(42)43/h6-7,13-14,23-24,28-31,33,45H,8-12,15-22,41H2,1-5H3,(H,46,51)(H,47,53)(H,48,54)(H,49,52)(H,56,57)(H4,42,43,44)/t28-,29-,30-,31-,33+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
631n/an/an/an/an/an/an/an/a



Medical University of South Carolina

Curated by ChEMBL


Assay Description
Displacement of [125I]I-Tyr(3)NT from human NTR1


J Med Chem 52: 1803-13 (2009)


Article DOI: 10.1021/jm801072v
BindingDB Entry DOI: 10.7270/Q2VD6Z9D
More data for this
Ligand-Target Pair
Dopamine receptor D2L/neurotensin receptor NTS1


(Homo sapiens (Human))
BDBM50257199
PNG
((S)-2-((S)-2-((S)-2-((S)-1-((S)-6-amino-2-(5-guani...)
Show SMILES CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)CCCCN=C(N)N)C(C)(C)C)C(O)=O |r,wU:8.8,wD:26.27,12.24,4.4,33.41,(40.62,-38.86,;40.62,-37.31,;41.99,-36.61,;39.33,-36.48,;39.39,-34.94,;38.1,-34.11,;36.73,-34.82,;36.67,-36.36,;35.44,-33.99,;34.07,-34.69,;32.78,-33.86,;32.85,-32.32,;31.4,-34.57,;31.33,-36.11,;32.63,-36.94,;34.06,-36.38,;35.04,-37.57,;34.2,-38.86,;34.61,-40.35,;33.53,-41.44,;32.04,-41.04,;31.64,-39.56,;32.72,-38.48,;30.1,-33.74,;28.74,-34.46,;27.45,-33.63,;28.67,-36.01,;29.89,-36.97,;29.35,-38.39,;27.8,-38.39,;27.38,-36.87,;26.06,-36.09,;26.07,-34.55,;24.71,-36.84,;24.7,-38.39,;23.36,-39.16,;23.35,-40.7,;22.02,-41.46,;22,-43,;23.38,-36.07,;22.04,-36.84,;22.03,-38.37,;20.71,-36.06,;20.72,-34.52,;19.39,-33.73,;19.4,-32.19,;18.07,-31.41,;18.09,-29.87,;16.76,-29.1,;19.42,-29.11,;35.52,-32.45,;35.51,-30.9,;37.06,-32.48,;33.98,-32.42,;40.76,-34.24,;42.05,-35.07,;40.84,-32.7,)|
Show InChI InChI=1S/C40H64N10O7/c1-24(2)21-30(38(56)57)48-36(54)33(40(3,4)5)49-34(52)29(22-25-23-45-27-14-7-6-13-26(25)27)47-35(53)31-16-12-20-50(31)37(55)28(15-8-10-18-41)46-32(51)17-9-11-19-44-39(42)43/h6-7,13-14,23-24,28-31,33,45H,8-12,15-22,41H2,1-5H3,(H,46,51)(H,47,53)(H,48,54)(H,49,52)(H,56,57)(H4,42,43,44)/t28-,29-,30-,31-,33+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 842n/an/an/an/an/an/a



Medical University of South Carolina

Curated by ChEMBL


Assay Description
Displacement of [125I]I-Tyr(3)NT from human NTR1


J Med Chem 52: 1803-13 (2009)


Article DOI: 10.1021/jm801072v
BindingDB Entry DOI: 10.7270/Q2VD6Z9D
More data for this
Ligand-Target Pair
Dopamine receptor D2L/neurotensin receptor NTS1


(Homo sapiens (Human))
BDBM50257199
PNG
((S)-2-((S)-2-((S)-2-((S)-1-((S)-6-amino-2-(5-guani...)
Show SMILES CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)CCCCN=C(N)N)C(C)(C)C)C(O)=O |r,wU:8.8,wD:26.27,12.24,4.4,33.41,(40.62,-38.86,;40.62,-37.31,;41.99,-36.61,;39.33,-36.48,;39.39,-34.94,;38.1,-34.11,;36.73,-34.82,;36.67,-36.36,;35.44,-33.99,;34.07,-34.69,;32.78,-33.86,;32.85,-32.32,;31.4,-34.57,;31.33,-36.11,;32.63,-36.94,;34.06,-36.38,;35.04,-37.57,;34.2,-38.86,;34.61,-40.35,;33.53,-41.44,;32.04,-41.04,;31.64,-39.56,;32.72,-38.48,;30.1,-33.74,;28.74,-34.46,;27.45,-33.63,;28.67,-36.01,;29.89,-36.97,;29.35,-38.39,;27.8,-38.39,;27.38,-36.87,;26.06,-36.09,;26.07,-34.55,;24.71,-36.84,;24.7,-38.39,;23.36,-39.16,;23.35,-40.7,;22.02,-41.46,;22,-43,;23.38,-36.07,;22.04,-36.84,;22.03,-38.37,;20.71,-36.06,;20.72,-34.52,;19.39,-33.73,;19.4,-32.19,;18.07,-31.41,;18.09,-29.87,;16.76,-29.1,;19.42,-29.11,;35.52,-32.45,;35.51,-30.9,;37.06,-32.48,;33.98,-32.42,;40.76,-34.24,;42.05,-35.07,;40.84,-32.7,)|
Show InChI InChI=1S/C40H64N10O7/c1-24(2)21-30(38(56)57)48-36(54)33(40(3,4)5)49-34(52)29(22-25-23-45-27-14-7-6-13-26(25)27)47-35(53)31-16-12-20-50(31)37(55)28(15-8-10-18-41)46-32(51)17-9-11-19-44-39(42)43/h6-7,13-14,23-24,28-31,33,45H,8-12,15-22,41H2,1-5H3,(H,46,51)(H,47,53)(H,48,54)(H,49,52)(H,56,57)(H4,42,43,44)/t28-,29-,30-,31-,33+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 783n/an/an/an/a



Medical University of South Carolina

Curated by ChEMBL


Assay Description
Agonist activity at NTR1 in human HT-29 cells assessed as increase in intracellular calcium concentration by FLIPR assay


J Med Chem 52: 1803-13 (2009)


Article DOI: 10.1021/jm801072v
BindingDB Entry DOI: 10.7270/Q2VD6Z9D
More data for this
Ligand-Target Pair